MTNB - Matinas BioPharma Holdings - Stock Forecast

Coverage Performance Price Targets & Ratings Chart Insider Trading

with an average price target of $2.38. This is a potential upside of $2.2 (1222.22%) from yesterday's end of day stock price of $0.18.

Matinas BioPharma Holdings's activity chart (see below) currently has 4 price targets and 8 ratings on display.

Stock Analyst Price Targets - Review

Most recent stock forecast was given by YASMEEN RAHIMI from PIPER SANDLER on 13-Sep-2021. First documented stock forecast 27-Jan-2020.

Edward Tenthoff Yasmeen Rahimi

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

2 years 7 months 10 days ago

0/2 (0%)

$3.19 (393.83%)

Hold

2 years 11 months 12 days ago

0/2 (0%)

$1.2 (150.00%)

Show more analysts

What is MTNB (Matinas BioPharma Holdings) average time for price targets to be met?

On average it took 0 days on average for the stock forecasts to be realized with a an average price target met ratio 0

Which analyst has the current highest performing score on MTNB (Matinas BioPharma Holdings) with a proven track record?

EDWARD TENTHOFF

Which analyst has the current lower performing score on MTNB (Matinas BioPharma Holdings) with a proven track record?

YASMEEN RAHIMI

Which analyst has the most public recommendations on MTNB (Matinas BioPharma Holdings)?

Edward Tenthoff works at PIPER SANDLER and has 7 price targets and 6 ratings on MTNB

Which analyst is the currently most bullish on MTNB (Matinas BioPharma Holdings)?

Yasmeen Rahimi with highest potential upside - $0

Which analyst is the currently most reserved on MTNB (Matinas BioPharma Holdings)?

Edward Tenthoff with lowest potential downside - -$0